Literature DB >> 34160807

CRISPR/Cas9 to Silence Long Non-Coding RNAs.

Ingrid Arctander Rosenlund1, George A Calin2,3, Mihnea P Dragomir4, Erik Knutsen5.   

Abstract

Knockout (KO) of long non-coding RNAs (lncRNAs) enables functional characterization of this still poorly described group of transcripts. One of the most efficient and simplest methods to achieve complete KO of a lncRNA is by employing CRISPR/Cas gene editing. As most lncRNAs are not well annotated, their individual functional regions are often not defined, and the majority of the transcripts are not affected by single nucleotide mutations. Therefore, CRISPR/Cas KO is more challenging for lncRNAs as compared to KO of protein coding genes. Strategies for lncRNAs KO include complete removal of the entire gene, removal of the promoter and transcriptional start site, abolishing exon-exon junctions, or removing the transcriptional termination site. Here, we describe the methodology to perform CRISPR/Cas9 KO of lncRNAs in vitro using electroporation as the method of transfection of presynthesized single guide RNAs (sgRNAs) and Cas9 enzyme.

Entities:  

Keywords:  CRISPR/Cas9; Electroporation; Gene editing; Knockout; Long non-coding RNA

Year:  2021        PMID: 34160807     DOI: 10.1007/978-1-0716-1581-2_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

Review 1.  RNA-guided genetic silencing systems in bacteria and archaea.

Authors:  Blake Wiedenheft; Samuel H Sternberg; Jennifer A Doudna
Journal:  Nature       Date:  2012-02-15       Impact factor: 49.962

2.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

Review 3.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

4.  Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.

Authors:  Giedrius Gasiunas; Rodolphe Barrangou; Philippe Horvath; Virginijus Siksnys
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

Review 5.  Annotation and Classification of CRISPR-Cas Systems.

Authors:  Kira S Makarova; Eugene V Koonin
Journal:  Methods Mol Biol       Date:  2015

6.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

7.  Small CRISPR RNAs guide antiviral defense in prokaryotes.

Authors:  Stan J J Brouns; Matthijs M Jore; Magnus Lundgren; Edze R Westra; Rik J H Slijkhuis; Ambrosius P L Snijders; Mark J Dickman; Kira S Makarova; Eugene V Koonin; John van der Oost
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

Review 8.  An updated evolutionary classification of CRISPR-Cas systems.

Authors:  Kira S Makarova; Yuri I Wolf; Omer S Alkhnbashi; Fabrizio Costa; Shiraz A Shah; Sita J Saunders; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Daniel H Haft; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Rebecca M Terns; Michael P Terns; Malcolm F White; Alexander F Yakunin; Roger A Garrett; John van der Oost; Rolf Backofen; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2015-09-28       Impact factor: 60.633

9.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

10.  A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes.

Authors:  Daniel H Haft; Jeremy Selengut; Emmanuel F Mongodin; Karen E Nelson
Journal:  PLoS Comput Biol       Date:  2005-11-11       Impact factor: 4.475

View more
  3 in total

Review 1.  LncRNAs as the Regulators of Brain Function and Therapeutic Targets for Alzheimer's Disease.

Authors:  Yuqing Liu; Xin Chen; Yutong Che; Hongli Li; Zheyu Zhang; Weijun Peng; Jingjing Yang
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

2.  Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue.

Authors:  Marta Tellez-Gabriel; Xavier Tekpli; Trine M Reine; Beate Hegge; Stephanie R Nielsen; Meng Chen; Line Moi; Lisa Svartdal Normann; Lill-Tove R Busund; George A Calin; Gunhild M Mælandsmo; Maria Perander; Achilleas D Theocharis; Svein O Kolset; Erik Knutsen
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

Review 3.  Functional interplay between long non-coding RNAs and Breast CSCs.

Authors:  Bashdar Mahmud Hussen; Ramiar Kamal Kheder; Sara Tharwat Abdullah; Hazha Jamal Hidayat; Heshu Sulaiman Rahman; Abbas Salihi; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Cancer Cell Int       Date:  2022-07-21       Impact factor: 6.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.